Muscular Dystrophy Association and AFM-Téléthon Announce $510,000 Research Grant Awards Advancing Treatments for Mitochondrial Myopathies and ALS
18 déc. 2024 08h44 HE
|
Muscular Dystrophy Association
New York, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and AFM-Téléthon (the French muscular dystrophy association) are proud to announce the awarding of two...
Muscular Dystrophy Association Announces Over $5 Million in Research Grants to Advance Neuromuscular Disease Research
16 déc. 2024 08h42 HE
|
Muscular Dystrophy Association
New York, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the awarding of 21 new grants with a total funding commitment of over $5 million toward...
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
06 déc. 2024 17h30 HE
|
Athira Pharma, Inc.
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and...
NFL Players Nyheim Hines, Raheem Blackshear, Nick Scott, and Wear Custom Cleats to Support Muscular Dystrophy Association for the NFL My Cause My Cleats Campaign
27 nov. 2024 09h00 HE
|
Muscular Dystrophy Association
New York, Nov. 27, 2024 (GLOBE NEWSWIRE) -- This December, hundreds of NFL players are donning custom-designed cleats as part of the 8th annual My Cause My Cleats campaign, spotlighting non-profit...
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
21 nov. 2024 09h00 HE
|
DANNCE.AI
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform.
Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
20 nov. 2024 05h00 HE
|
Verge Genomics
— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics’ AI-Enabled, All-in-Human CONVERGE® Platform — Demonstration of the Robust Predictive Power of CONVERGE® - 83% of...
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
19 nov. 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Agenda Announced for 2025 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease
14 nov. 2024 09h00 HE
|
Muscular Dystrophy Association
New York, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association today announced the agenda including tracks and Chairs for the 2025 MDA Clinical & Scientific Conference being held...
Fitness World Canada Raises $20,000 to Support ALS Research and Patient Care
04 nov. 2024 11h03 HE
|
Fitness World
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Fitness World Canada and its community successfully raised $20,000 in September for their partnership with Augie’s Quest, an...
Muscular Dystrophy Association Shines a Spotlight on National Family Caregivers Awareness Month in November
31 oct. 2024 09h12 HE
|
Muscular Dystrophy Association
New York, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) proudly highlights National Family Caregivers Awareness Month this November. MDA's month-long campaign emphasizes...